Abiraterone acetate lipid formulations
First Claim
Patent Images
1. A composition, consisting of:
- abiraterone acetate; and
a lipid matrix, consisting of (a) a fatty acid ester of glycerol or mixtures thereof in an amount of from 10 wt % to 60 wt % of the composition;
(b) a propylene glycol fatty acid ester, or a polyoxylglyceride, or a combination thereof, wherein the propylene glycol fatty acid ester, or the polyoxylglyceride, or the combination thereof is present in an amount of from 20 wt % to 60 wt % of the composition; and
(c) a surfactant present in an amount of from 15 wt % to 60 wt % of the composition; and
wherein the abiraterone acetate is solubilized in the lipid matrix.
1 Assignment
0 Petitions
Accused Products
Abstract
Abiraterone acetate lipid formulations.
-
Citations
15 Claims
-
1. A composition, consisting of:
-
abiraterone acetate; and a lipid matrix, consisting of (a) a fatty acid ester of glycerol or mixtures thereof in an amount of from 10 wt % to 60 wt % of the composition;
(b) a propylene glycol fatty acid ester, or a polyoxylglyceride, or a combination thereof, wherein the propylene glycol fatty acid ester, or the polyoxylglyceride, or the combination thereof is present in an amount of from 20 wt % to 60 wt % of the composition; and
(c) a surfactant present in an amount of from 15 wt % to 60 wt % of the composition; and
wherein the abiraterone acetate is solubilized in the lipid matrix. - View Dependent Claims (3, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)
-
-
2. A composition, consisting of:
-
abiraterone acetate; a lipid matrix, consisting of (a) a fatty acid ester of glycerol or mixtures thereof in an amount of from 10 wt % to 60 wt % of the composition;
(b) a propylene glycol fatty acid ester, or a polyoxylglyceride, or a combination thereof, wherein the propylene glycol fatty acid ester, or the polyoxylglyceride, or the combination thereof is present in an amount of from 20 wt % to 60 wt % of the composition; and
(c) a surfactant present in an amount of from 15 wt % to 60 wt % of the composition; and
wherein the abiraterone acetate is solubilized in the lipid matrix; andan antioxidant. - View Dependent Claims (4)
-
Specification